We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$12.3B
AUM Growth
+$18.3M
Cap. Flow
-$277M
Cap. Flow %
-2.25%
Top 10 Hldgs %
11.78%
Holding
2,232
New
70
Increased
794
Reduced
1,229
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 14.17%
2 Financials 10.74%
3 Healthcare 10.43%
4 Consumer Discretionary 8.1%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIK
2076
DELISTED
Michaels Stores, Inc
MIK
$93K ﹤0.01%
10,709
-6,095
-36% -$64.4K
NBR icon
2077
Nabors Industries
NBR
$1.27B
$87K ﹤0.01%
596
+97
+19% +$15.5K
ENDP
2078
DELISTED
Endo International plc
ENDP
$84K ﹤0.01%
20,453
-9
-0% -$57
CALX icon
2079
Calix
CALX
$2.26B
$82K ﹤0.01%
12,361
-294
-2% -$1.99K
SIGA icon
2080
SIGA Technologies
SIGA
$235M
$82K ﹤0.01%
14,312
-327
-2% -$1.81K
RYAM icon
2081
Rayonier Advanced Materials
RYAM
$604M
$80K ﹤0.01%
12,402
-4,893
-28% -$50.9K
TWI icon
2082
Titan International
TWI
$466M
$80K ﹤0.01%
16,426
-6,538
-28% -$35.6K
JCP
2083
DELISTED
J.C. Penney Company, Inc.
JCP
$80K ﹤0.01%
70,102
-27,152
-28% -$32.2K
ASNA
2084
DELISTED
Ascena Retail Group, Inc.
ASNA
$78K ﹤0.01%
6,423
-468
-7% -$9.93K
EXPR
2085
DELISTED
Express, Inc.
EXPR
$76K ﹤0.01%
1,389
-564
-29% -$38.5K
VSI
2086
DELISTED
Vitamin Shoppe Inc.
VSI
$72K ﹤0.01%
18,380
-7,680
-29% -$39.7K
ASG
2087
Liberty All-Star Growth Fund
ASG
$325M
$70K ﹤0.01%
+11,902
New +$67.4K
SRCI
2088
DELISTED
SRC Energy Inc
SRCI
$70K ﹤0.01%
14,034
-4,304
-23% -$23.4K
SUP
2089
DELISTED
Superior Industries International
SUP
$64K ﹤0.01%
18,383
-8,042
-30% -$37K
RRD
2090
DELISTED
RR Donnelley & Sons Co.
RRD
$60K ﹤0.01%
30,593
-2,944
-9% -$9.72K
IVC
2091
DELISTED
Invacare Corporation
IVC
$58K ﹤0.01%
11,269
-4,481
-28% -$29.2K
HCR
2092
DELISTED
Hi-Crush Inc. Common Stock
HCR
$43K ﹤0.01%
17,487
-29
-0.2% -$91
ASRT
2093
DELISTED
Assertio
ASRT
$41K ﹤0.01%
198
-75
-27% -$17.9K
CBL
2094
DELISTED
CBL& Associates Properties, Inc.
CBL
$37K ﹤0.01%
35,127
-13,319
-27% -$15.4K
BNED icon
2095
Barnes & Noble Education
BNED
$431M
$34K ﹤0.01%
100
-39
-28% -$15K
SPN
2096
DELISTED
Superior Energy Services, Inc.
SPN
$34K ﹤0.01%
2,595
-974
-27% -$28.7K
FTR
2097
DELISTED
Frontier Communications Corp.
FTR
$30K ﹤0.01%
17,009
-6,409
-27% -$13.1K
CDR
2098
DELISTED
Cedar Realty Trust, Inc
CDR
$28K ﹤0.01%
1,604
-581
-27% -$11.6K
DF
2099
DELISTED
Dean Foods Company
DF
$26K ﹤0.01%
28,162
-11,376
-29% -$18.3K
ABM icon
2100
ABM Industries
ABM
$2.81B
-6,137
Closed -$223K

Similar funds

Guggenheim Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Guggenheim Capital held 2,232 positions worth $12.3B, up 0.15% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Guggenheim Capital's Q2 2019 filing shows 70 new, 794 increased, 1,229 reduced and 133 closed positions. Its largest new stake was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 333,216 shares worth $33.9M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $86.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q2 2019 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 333,216 shares worth $33.9M.
  • Guggenheim Capital added most to Iron Mountain in Q2 2019, an estimated $9.18M increase.
  • Guggenheim Capital's biggest Q2 2019 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $86.5M.
  • Guggenheim Capital fully exited Invesco Solar ETF in Q2 2019, selling an estimated $17.6M.
  • Guggenheim Capital's ten largest holdings make up 12% of its $12.3B portfolio in Q2 2019.
  • Guggenheim Capital opened 70 new positions and closed 133 in Q2 2019.
  • Guggenheim Capital's portfolio value rose 0.15% quarter-over-quarter to $12.3B.

Based on Guggenheim Capital's 13F filing for Q2 2019, filed 14 Aug 2019.